Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using Thalidomide

NCT00787436 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00787436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00787436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using Thalidomide
Lead sponsor
The Cleveland Clinic
Phase
Phase 3
Overall status
Withdrawn
Start date
May 31, 2006
Completion date
January 31, 2010
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal hemorrhage, portal hypertension